TUMORI J, cilt.96, sa.3, ss.400-404, 2010 (SCI-Expanded)
Aims. To evaluate activity and toxicity of cisplatin plus docetaxel combination in the first-line treatment of chemotherapy-naive patients with metastatic non-small cell lung cancer.